These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 27480577)
1. Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review. Park YJ; Martin EG Health Serv Res; 2017 Oct; 52(5):1685-1728. PubMed ID: 27480577 [TBL] [Abstract][Full Text] [Related]
2. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis. Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722 [TBL] [Abstract][Full Text] [Related]
3. Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence. Pimentel CB; Lapane KL; Briesacher BA Drugs Aging; 2013 Sep; 30(9):701-20. PubMed ID: 23729166 [TBL] [Abstract][Full Text] [Related]
4. Medicare Part D's effects on elderly patients' drug costs and utilization. Ketcham JD; Simon KI Am J Manag Care; 2008 Nov; 14(11 Suppl):SP14-22. PubMed ID: 18991476 [TBL] [Abstract][Full Text] [Related]
5. Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act. Bonakdar Tehrani A; Cunningham PJ Med Care; 2017 Jan; 55(1):43-49. PubMed ID: 27547949 [TBL] [Abstract][Full Text] [Related]
6. Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications. Karaca-Mandic P; Swenson T; Abraham JM; Kane RL Health Serv Res; 2013 Aug; 48(4):1311-33. PubMed ID: 23278369 [TBL] [Abstract][Full Text] [Related]
7. The Medicare Part D doughnut hole: effect on pharmacy utilization. Sun SX; Lee KY Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394 [TBL] [Abstract][Full Text] [Related]
8. Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance. Polinski JM; Brookhart MA; Glynn RJ; Schneeweiss S J Clin Psychopharmacol; 2012 Feb; 32(1):3-10. PubMed ID: 22198455 [TBL] [Abstract][Full Text] [Related]
9. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans. Patel UD; Davis MM J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016 [TBL] [Abstract][Full Text] [Related]
10. Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Briesacher BA; Zhao Y; Madden JM; Zhang F; Adams AS; Tjia J; Ross-Degnan D; Gurwitz JH; Soumerai SB Med Care; 2011 Sep; 49(9):834-41. PubMed ID: 21544002 [TBL] [Abstract][Full Text] [Related]
11. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D. Blumberg DM; Prager AJ; Liebmann JM JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853 [TBL] [Abstract][Full Text] [Related]
12. Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV. Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey MW; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Golub ET; Adimora AA Med Care; 2018 Jan; 56(1):47-53. PubMed ID: 29227443 [TBL] [Abstract][Full Text] [Related]
13. The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes. Choi YJ; Jia H; Gross T; Weinger K; Stone PW; Smaldone AM Diabetes Care; 2017 Apr; 40(4):502-508. PubMed ID: 27803119 [TBL] [Abstract][Full Text] [Related]
14. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008. Cheng LI; Rascati KL Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663 [TBL] [Abstract][Full Text] [Related]
15. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings. Song H; Adamson A; Mostaghimi A JAMA Dermatol; 2017 Aug; 153(8):755-759. PubMed ID: 28453645 [TBL] [Abstract][Full Text] [Related]
16. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912 [TBL] [Abstract][Full Text] [Related]
17. Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review. Polinski JM; Kilabuk E; Schneeweiss S; Brennan T; Shrank WH J Am Geriatr Soc; 2010 Sep; 58(9):1764-79. PubMed ID: 20863336 [TBL] [Abstract][Full Text] [Related]
18. The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility. Liu FX; Alexander GC; Crawford SY; Pickard AS; Hedeker D; Walton SM Health Serv Res; 2011 Aug; 46(4):1104-23. PubMed ID: 21609328 [TBL] [Abstract][Full Text] [Related]
19. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries. Thatcher EE; Vanwert EM; Erickson SR J Pharm Pract; 2013 Jun; 26(3):248-52. PubMed ID: 23178417 [TBL] [Abstract][Full Text] [Related]
20. Noncompliance in the use of cardiovascular medications in the Medicare Part D population. Blackwell SA; Baugh DK; Montgomery MA; Ciborowski GM; Waldron CJ; Riley GF Medicare Medicaid Res Rev; 2011 Dec; 1(4):. PubMed ID: 22340781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]